An observational study in Corona Virus Infection, sponsored by Fatima Memorial Hospital. Completed at 1 site in Pakistan. Open to participants aged 10 Years to 95 Years. Per ClinicalTrials.gov, last updated 2022-02-28.
Sponsored by Fatima Memorial Hospital · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 98 studies in COVID-19 with a site in Pakistan — 3 open to participants now, 4 under way, 2 of them phase 3. COVID-19 · Pakistan.
Among the 98 studies in COVID-19 with a site in Pakistan, this one is the 18th largest by enrollment of the 27 observational ones that give a count, is one of 62 that started in 2020, is one of 27 observational ones, and was the 83rd registered.
7,996 studies on the registry are indexed under COVID-19; 469 are open to participants now.
Browse COVID-19 studies →3 of the 98 studies in COVID-19 with a site in Pakistan are open now. Recruiting first, the newest first:
Bahria University · Sites in Pakistan
Ages 18–25 · Healthy volunteers
University of Oxford · Sites in Pakistan, Brazil, Laos and 2 more countries
Ages 18–60
UMC Utrecht · Sites in Pakistan, United States, Australia and 26 more countries
Ages 28 days+
A study can be open while its sites in Pakistan have not opened yet or have stopped. Only those recruiting at a site in Pakistan →
Of the 356 COVID-19 studies recruiting now, 205 (58%) set no upper age limit and 84 (24%) stop at 75 or younger; 90 take children under 18; 135 take healthy volunteers.
This study: 10 Years to 95 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
98 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 8 · Phase 2 15 · Phase 3 22 · Phase 4 5
First in 2016; this study’s year is marked. 62 started in 2020.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 202 is below the median of 268 across 3,209 observational studies indexed under COVID-19.
Median enrollment 125 across the 71 interventional studies, 373 across the 27 observational. Of the 68 that completed or were terminated, 5 (7%) have results posted.
This tab as a report to print or save as PDF → With an account.
9 of 98 have an industry lead sponsor. The 10 most frequent:
Fatima Memorial Hospital is the lead sponsor of 12 studies on the registry; 3 are open to participants now.
Fatima Memorial Hospital has 2 studies filed under COVID-19 — fewer than ten, so there is no comparison to draw.
1 of the studies in COVID-19 with a site in Pakistan that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05041907University of OxfordFinding Treatments for COVID-19: A Trial of Antiviral Pharmacodynamics in Early Symptomatic COVID-19 (PLATCOV) | 2027-01 |
Add it to your calendar (.ics) → With an account.
Among the 98 studies in COVID-19 with a site in Pakistan, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Demographic, Clinical and laboratory data as well as outcome of total 202 COVID-19 patients who were Polymerase Chain Reaction (PCR) positive and admitted in Fatima memorial Hospital, Lahore, Pakistan, was collected during first and other waves. Data of First wave is from May 2020 to July 2020, second wave from early November to Mid December 2020 and third wave from Mid march to June 2021. Investigator analyzed the data on basis of Systemic immune inflammatory index (SII) as well hematological parameters of First Wave were compared to other waves of COVID-19.
7,996 studies on the registry are indexed under COVID-19; 469 are open to participants now.
This study's enrollment of 202 is below the median of 268 across 3,209 observational studies indexed under COVID-19.
Browse COVID-19 studies →Fatima Memorial Hospital is the lead sponsor of 12 studies on the registry; 3 are open to participants now.
Compared within COVID-19, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Coronavirus Infections. The counts are of registry records indexed under each term, refreshed daily. How we classify →
COVID-19 Positive Hospitalized patients, of all genders and all age group.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Cytopenias in Hospitalized Patients of COVID-19 During First and Other waves
extent of cytopenias is being measured in COVID-19 hospitalized patients.
Time frame: 4 weeks
Ran from May 2020 to primary completion in Jun 2021, 13 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Feb 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Fatima Memorial Hospital